AI assistant
PFIZER INC — Director's Dealing 2024
Feb 27, 2024
29831_dirs_2024-02-27_a5b166ab-fe44-4277-a59c-6136f6268085.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2024-02-23
Reporting Person: BOSHOFF CHRISTOFFEL (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-23 | Common Stock | M | 9752.0000 | $27.3400 | Acquired | 148703.0000 | Direct |
| 2024-02-23 | Common Stock | F | 458.0000 | $27.7600 | Disposed | 148245.0000 | Direct |
| 2024-02-23 | Common Stock | F | 675.0000 | $27.7600 | Disposed | 147570.0000 | Direct |
| 2024-02-23 | Common Stock | F | 7881.0000 | $27.3700 | Disposed | 139689.0000 | Direct |
| 2024-02-24 | Common Stock | F | 300.0000 | $27.7600 | Disposed | 139389.0000 | Direct |
| 2024-02-25 | Common Stock | A | 15455.0000 | $0.0000 | Acquired | 154844.0000 | Direct |
| 2024-02-25 | Common Stock | F | 1403.0000 | $27.7600 | Disposed | 153441.0000 | Direct |
| 2024-02-25 | Common Stock | F | 4794.0000 | $27.7600 | Disposed | 148647.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-23 | Stock Appreciation Rights | $27.3400 | M | 9752.0000 | Disposed | 2024-02-23 | Common Stock (9752.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 624.0000 | Indirect |
Footnotes
F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
F3: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F4: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F5: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
F6: Price is the closing price of Pfizer common stock on February 23, 2024.
F7: The reported transaction constitutes the earn-out of performance share awards (including dividend equivalents thereon).
F8: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of performance share awards (including dividend equivalents thereon).